Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia

Patients with relapsed acute myeloid leukemia (AML) have unfavorable prognosis and require innovative therapeutic approaches. In this study we used fludarabine combined with a middle dose of cytosine arabinoside (Ara-C), mitoxantrone and granulocyte-colony stimulating factor (G-CSF) as a salvage the...

Descripción completa

Detalles Bibliográficos
Autores principales: LUO, SHENG, CAI, FANGFANG, JIANG, LEI, ZHANG, SHENGHUI, SHEN, ZHIJIAN, SUN, LAN, GAO, SHENMENG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570250/
https://www.ncbi.nlm.nih.gov/pubmed/23407597
http://dx.doi.org/10.3892/etm.2013.917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570250/
https://www.ncbi.nlm.nih.gov/pubmed/23407597
http://dx.doi.org/10.3892/etm.2013.917

Ejemplares similares